Information Provided By:
Fly News Breaks for May 14, 2018
May 14, 2018 | 09:09 EDT
As previously reported, Jefferies analyst Johnny Kin Man Wong downgraded China Biologic Products to Hold from Buy and cut his price target on shares to $83 from $97 citing a lack of visibility ahead. In a research note to investors, the analyst said healthcare reforms are likely to impact the company more harshly than originally expected as hospitals continue to hold back from ordering despite what he feels is healthy end demand.
News For CBPO From the Last 2 Days
There are no results for your query CBPO
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.